Filtros de búsqueda

Lista de obras de

A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study

artículo científico publicado en 2018

A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia

artículo científico publicado en 2004

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

artículo científico publicado en 2018

A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia

artículo científico publicado en 2013

A phase I study of fludarabine, cytarabine, and oxaliplatin therapy in patients with relapsed or refractory acute myeloid leukemia

artículo científico publicado en 2014

A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes

artículo científico publicado en 2002

A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age.

artículo científico publicado en 2015

A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome

artículo científico publicado en 2003

Accounting for patient heterogeneity in phase II clinical trials

artículo científico publicado en 2008

Acute Myeloid Leukemia Measurable Residual Disease Detection by Flow Cytometry in Peripheral Blood Versus Bone Marrow

scientific article published on 07 October 2020

Acute myeloid leukaemia

artículo científico publicado en 2006

Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients

artículo científico publicado en 2010

Acute myeloid leukemia stem cells and CD33-targeted immunotherapy

artículo científico publicado en 2012

Acute myeloid leukemia with normal cytogenetics

artículo científico publicado en 2012

Acute myeloid leukemia: 2021 update on risk-stratification and management

artículo científico publicado en 2020

Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes

artículo científico publicado en 2005

Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia

artículo científico publicado en 2003

Adding arabinosylcytosine to idarubicin induction therapy may not improve survival for people with newly diagnosed acute promyelocytic leukaemia.

artículo científico publicado en 2003

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials

artículo científico publicado en 2014

Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center

artículo científico publicado en 2005

Adult acute myeloid leukemia

artículo científico publicado en 2006

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

artículo científico publicado en 2015

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults

artículo científico publicado en 2014

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

artículo científico publicado en 2019

Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy

artículo científico publicado en 2004

Anaplastic large cell lymphoma with involvement of the pancreas presenting as panniculitis in a patient with a history of acute myeloid leukemia--case report and review of the literature.

artículo científico publicado en 2006

Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin

artículo científico publicado en 2013

Association of cancer-related symptoms with physiological parameters.

artículo científico publicado en 2002

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

artículo científico publicado en 2004

Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study

artículo científico publicado en 2007

Blood counts at time of complete remission provide additional independent prognostic information in acute myeloid leukemia

artículo científico publicado en 2008

Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia.

artículo científico publicado en 2017

Building and validating a prognostic index for biomarker studies.

artículo científico publicado en 2006

C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome

artículo científico publicado en 2004

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia

artículo científico publicado en 2020

CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome

artículo científico publicado en 2005

Cardiotoxicity in African-American patients treated with arsenic trioxide for acute promyelocytic leukemia

artículo científico publicado en 2005

Central nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation

artículo científico publicado en 2014

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

scientific article published on 20 August 2019

Circulating Blasts Following Chemotherapy in Pediatric Patients: Implications for Complete Remission Definition in Acute Leukemia ⬇️

artículo científico publicado el 1 de octubre de 2003

Clinical correlation of circulating heat shock protein 70 in acute leukemia

artículo científico publicado en 2009

Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome

artículo científico publicado en 2002

Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome

artículo científico publicado en 2002

Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia

artículo científico publicado en 2011

Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system

artículo científico publicado en 2011

Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

artículo científico publicado en 2005

Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia

artículo científico publicado en 2007

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

artículo científico publicado en 2014

Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid.

artículo científico publicado en 2015

Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping.

artículo científico publicado en 2007

Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse

artículo científico publicado en 2003

Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels

artículo científico publicado en 2002

Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia

scientific article published on 19 December 2020

Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms

scientific article published on 13 September 2020

Contribution of β-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS) ⬇️

artículo científico publicado el 8 de mayo de 2003

Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia

artículo científico publicado en 2014

Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemia

artículo científico publicado en 2015

Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia

scientific article published on 10 July 2019

Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study

artículo científico publicado en 2013

Decitabine in older adults with acute myeloid leukemia: why was the dream broken?

artículo científico publicado en 2013

Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML.

artículo científico publicado en 2018

Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.

artículo científico publicado en 2009

Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.

artículo científico publicado en 2018

Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality

artículo científico publicado en 2017

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

artículo científico publicado en 2016

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

artículo científico publicado en 2009

Diagnostic utility of bronchoscopy in adults with acute myeloid leukemia and other high-grade myeloid neoplasms

artículo científico publicado en 2019

Differences in CD33 intensity between various myeloid neoplasms

artículo científico publicado en 2002

Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?

artículo científico publicado en 2015

Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia

artículo científico publicado en 2019

Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm

scientific article published on 04 October 2019

Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia

artículo científico publicado en 2015

Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AML.

artículo científico publicado en 2003

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

artículo científico publicado en 2010

Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome

artículo científico publicado en 2007

Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission

artículo científico publicado en 2015

Emerging treatments in acute myeloid leukemia: current standards and unmet challenges

artículo científico publicado en 2017

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.

artículo científico publicado en 2015

Empirical examination of the neutrophil criterion (>1500 microl(-1)) currently needed to declare CR in AML.

artículo científico publicado en 2003

Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival

artículo científico publicado en 2004

Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia

artículo científico

Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML).

artículo científico publicado en 2013

Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia

artículo científico publicado en 2002

Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis

artículo científico publicado en 2004

Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies

artículo científico publicado en 2004

FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype

artículo científico publicado en 2004

Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia

artículo científico publicado en 2014

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

artículo científico publicado en 2005

Flow cytometric demonstration of decrease in bone marrow leukemic blasts after 'Day 14' without further therapy in acute myeloid leukemia

artículo científico publicado en 2017

Follow-up issues in survivors of hematologic malignancies - Current stance and future perspectives

artículo científico publicado en 2020

Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission

artículo científico publicado en 2013

G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm

artículo científico publicado en 2015

Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study

artículo científico publicado en 2013

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

artículo científico publicado en 2003

Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia

artículo científico publicado en 2014

Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinosi

artículo científico publicado en 2002

Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia

artículo científico publicado en 2003

Gemtuzumab ozogamicin: time to resurrect?

artículo científico publicado en 2012

Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes

artículo científico publicado en 2003

Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome. ⬇️

artículo científico publicado en 2015

Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia

artículo científico publicado en 2015

Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions

artículo científico publicado en 2006

Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia

artículo científico publicado en 2012

Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia

artículo científico publicado en 2011

Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)

artículo científico publicado en 2018

Impact of residual normal metaphases in core binding factor acute myeloid leukemia

artículo científico publicado en 2011

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Incorporating Physical Function and Cognition Into Mortality Risk Assessment for Acute Myeloid Leukemia-Reply

artículo científico publicado en 2018

Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome

artículo científico publicado en 2003

Independent Associations Between Glomerular Filtration Rate and Serum Bilirubin Level and Early Mortality in Acute Myeloid Leukemia

artículo científico publicado en 2019

Independent prognostic significance of day 21 cytogenetic findings in newly-diagnosed acute myeloid leukemia or refractory anemia with excess blasts

artículo científico publicado en 2003

Induction mortality risk in adult acute myeloid leukemia

artículo científico publicado en 2006

Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia

artículo científico publicado en 2012

Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype ⬇️

artículo científico publicado el 17 de febrero de 2011

Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial

artículo científico publicado en 2016

Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.

artículo científico publicado en 2006

Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study

artículo científico publicado en 2010

Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation

artículo científico publicado el 1 de junio de 1995

Intravenous corticosteroids to reduce gemtuzumab ozogamicin infusion reactions

artículo científico publicado en 2003

Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy

artículo científico publicado en 2004

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

artículo científico publicado en 2005

Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia

artículo científico publicado en 2008

Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome

artículo científico publicado en 2003

Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome

artículo científico publicado en 2006

Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

artículo científico publicado en 2016

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

artículo científico publicado en 2008

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

scholarly article by Miguel A Sanz et al published 11 April 2019 in Blood

Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia

artículo científico publicado en 2003

Myelodysplastic syndrome is not merely "preleukemia"

artículo científico publicado en 2002

Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia

artículo científico publicado en 2008

Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia

artículo científico publicado en 2002

Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia

artículo científico publicado en 2003

Need for routine examination of left ventricular ejection fraction in patients with AML

artículo científico publicado en 2019

New designs for phase 2 clinical trials

artículo científico publicado en 2003

New study-designs to address the clinical complexity of acute myeloid leukemia

scientific article published on 22 January 2019

Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies

artículo científico publicado en 2006

Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?

artículo científico publicado en 2006

Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials

artículo científico publicado en 2013

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation

artículo científico publicado en 2011

Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design

artículo científico publicado en 2014

Outpatient induction and consolidation care strategies in acute myeloid leukemia

artículo científico publicado en 2019

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

scientific article published on 01 February 2020

Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study ⬇️

artículo científico publicado el 10 de marzo de 2011

Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia

artículo científico publicado en 2013

Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype

artículo científico publicado en 2007

PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival

artículo científico publicado en 2003

Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia

artículo científico publicado en 2006

Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms

artículo científico publicado en 2018

Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms

scholarly article by Anna B Halpern et al published 8 November 2018 in Haematologica

Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia

artículo científico publicado en 2020

Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes

artículo científico publicado en 2005

Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndrome

artículo científico publicado en 2008

Phase I study of bortezomib in refractory or relapsed acute leukemias

artículo científico publicado en 2004

Phase I study of oral topotecan in hematological malignancies ⬇️

artículo científico publicado el 15 de septiembre de 2003

Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia

scientific article published on 08 November 2019

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

artículo científico publicado en 2015

Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia

artículo científico publicado en 2009

Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome

artículo científico publicado en 2004

Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS

scientific article published on 16 November 2015

Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia

artículo científico publicado en 2011

Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3 ⬇️

artículo científico publicado el 23 de agosto de 2010

Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia

artículo científico publicado en 2002

Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia

artículo científico publicado en 2003

Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors

artículo científico publicado en 2006

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

artículo científico publicado en 2002

Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid

artículo científico publicado en 2005

Potential cure of acute myeloid leukemia : analysis of 1069 consecutive patients in first complete remission

scientific article published on 01 December 2007

Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia

scientific article published on 28 February 2014

Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes

artículo científico publicado en 2014

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

artículo científico publicado en 2011

Prediction of early death in adults with relapsed or refractory acute myeloid leukemia

artículo científico publicado en 2016

Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS.

artículo científico publicado en 2012

Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia

artículo científico publicado en 2020

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

artículo científico publicado en 2002

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

artículo científico publicado en 2005

Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials

artículo científico publicado en 2017

Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report

artículo científico publicado en 2015

Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia

artículo científico publicado en 2015

Prognostic significance of monocytosis in patients with myeloproliferative disorders

artículo científico publicado en 2006

Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia

artículo científico publicado en 2010

Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome

artículo científico publicado en 2002

Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept

artículo científico publicado en 2010

Prophylactic use of granulocyte colony-stimulating factor after consolidation therapy with high-dose cytarabine for acute myeloid leukemia

artículo científico publicado en 2013

Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

artículo científico publicado en 2006

Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome

artículo científico publicado en 2009

Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia

artículo científico publicado en 2006

Proteomics-based prediction of clinical response in acute myeloid leukemia

artículo científico publicado en 2009

Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia

artículo científico publicado en 2009

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.

artículo científico publicado en 2018

RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis.

artículo científico publicado en 2007

Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia

artículo científico publicado en 2008

Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high

artículo científico publicado en 2020

Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.

artículo científico publicado en 2003

Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia

artículo científico publicado en 2012

Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?

artículo científico publicado en 2020

Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML

scientific article published on 24 July 2020

Relapse and death during first remission in acute myeloid leukemia

artículo científico publicado en 2008

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia

artículo científico publicado en 2015

Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI.

artículo científico publicado en 2016

Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia ⬇️

artículo científico publicado el 23 de octubre de 2003

Relevance of clinical trials in acute myeloid leukaemia

artículo científico publicado en 2008

Reply to D. Przepiorka et al

scientific article published on 17 August 2015

Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis

artículo científico publicado en 2015

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

artículo científico publicado en 2004

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome

artículo científico publicado en 2006

Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia

artículo científico publicado en 2012

Revised Acute Myeloid Leukemia Composite Model Using the 2017 European LeukemiaNet Risk Classification

scientific article published on 01 July 2019

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

artículo científico publicado en 2003

Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome

artículo científico publicado en 2007

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials

artículo científico publicado en 2018

Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: Limitations of predictive models

scientific article published on 30 March 2020

Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm

artículo científico publicado en 2010

Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients

artículo científico publicado en 2013

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

artículo científico publicado en 2013

Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia

artículo científico publicado en 2006

Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia

artículo científico publicado en 2003

Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.

artículo científico publicado en 2006

Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data

artículo científico publicado en 2013

Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes

artículo científico publicado en 2004

Some ethical issues in phase II trials in acute leukemia

artículo científico publicado en 2005

Some ethical issues in phase II trials in acute leukemia

artículo científico publicado en 2006

Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia.

artículo científico publicado en 2015

Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia

artículo científico publicado en 2009

Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility

artículo científico publicado en 2020

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

artículo científico publicado en 2008

Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia

artículo científico publicado en 2003

The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemia

artículo científico publicado en 2013

The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells

artículo científico publicado en 2002

The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome

artículo científico publicado en 2003

The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations

scientific article published on 25 August 2006

The past and future of CD33 as therapeutic target in acute myeloid leukemia.

artículo científico publicado en 2014

The power of comparative studies

scientific article published on 05 November 2008

The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome

artículo científico publicado en 2003

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes

artículo científico publicado en 2008

The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients

artículo científico publicado en 2008

The role of gemtuzumab ozogamicin in acute leukaemia therapy

artículo científico publicado en 2006

The role of quizartinib in the treatment of acute myeloid leukemia

artículo científico

Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years

artículo científico publicado en 2008

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

artículo científico publicado en 2008

Time to repeal and replace response criteria for acute myeloid leukemia?

artículo científico publicado en 2018

Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival

artículo científico publicado en 2008

Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia

scientific article published on 16 January 2014

Truth or consequences: under-reporting of post-accrual changes in clinical trial design

scientific article published on 22 June 2020

Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm

artículo científico publicado en 2017

Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia

artículo científico publicado en 2013

Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy

artículo científico publicado en 2002

Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia

artículo científico publicado en 2005

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience

artículo científico publicado en 2003

Using short-term response information to facilitate adaptive randomization for survival clinical trials

artículo científico publicado en 2009

Widespread use of measurable residual disease in acute myeloid leukemia practice.

artículo científico publicado en 2018

XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38− cells in a phase 1/2 study of patients with relapsed/refractory AML ⬇️

artículo científico publicado el 1 de enero de 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda